Article
Genetic variation of Neurogenin 3 is slightly associated with hyperproinsulinaemia and progression toward type 2 diabetes.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association - 1 Mar 2008
Li J, Bergmann A, Reimann M, Schulze J, Bornstein S R, Schwarz P E H
Abstract excerpt
OBJECTIVE: Transcription factor Neurogenin 3 (NGN3) is considered as a candidate gene for the development of type 2 diabetes. The aim of the current study was to investigate the relevance of NGN3 variants for the clinical spectrum of diabetes development and disease progressions. RESEARCH DESIGN AND METHODS: A total of 552 subjects with increased risk of type 2 diabetes were investigated. They underwent a 75 g...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
